The presence of these neutralizing antibodies before the RSV challenge further restricted virus replication in the early stage of infection and thereby reduced the activation of CD8+ memory T cells that displayed immunopathogenic activity in control mice through the increased secretion of IFN-γ [222]. The gene discussed is CD8A; the disease is infection.